Clinical Trial Update: Long Term Effects of an Early Response to Certolizumab Pegol (CZP, Cimzia®) in Rheumatoid Arthritis (RA) Patients

View source ↗

Summary

This update summarizes long-term outcomes for rheumatoid arthritis patients who demonstrated an early response to certolizumab pegol (Cimzia). The study NCT0128…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• CIMZIA (CERTOLIZUMAB PEGOL)

Snippet

Sponsor: UCB Pharma | Conditions: Arthritis,Rheumatoid | Status: COMPLETED | Results posted: 2016-06-27